Graig Suvannavejh's
Stock Forecasts
7.41%
2/27 win trades
Price targets by Graig Suvannavejh
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Corvus Pharmaceuticals, Inc. CRVS | 11 months ago | $12 133.46% upside | $7.56 | StreetInsider | Previous targets (0) |
 Harmony Biosciences Holdings, Inc. HRMY | 11 months ago | $52 41.49% upside | $33.6 | TheFly | |
 IDEAYA Biosciences, Inc. IDYA | 12 months ago | $55 133.24% upside | $31.37 | StreetInsider | |
 Adverum Biotechnologies, Inc. ADVM | 12 months ago | $20 604.22% upside | $7.5 | StreetInsider | Previous targets (0) |
 Apellis Pharmaceuticals, Inc. APLS | 12 months ago | $39 46.50% upside | $36.73 | StreetInsider | |
 Corbus Pharmaceuticals Holdings, Inc. CRBP | 12 months ago | $74 710.51% upside | $51.58 | StreetInsider | Previous targets (0) |
 Immunocore Holdings plc IMCR | 12 months ago | $72 122.63% upside | $33.44 | StreetInsider | |
 Axsome Therapeutics, Inc. AXSM | 12 months ago | $106 -5.35% downside | $90.58 | StreetInsider | |
 Terns Pharmaceuticals, Inc. TERN | about 1 year ago | $10 58.47% upside | $7.79 | StreetInsider | Previous targets (0) |
 Neumora Therapeutics, Inc. Common Stock NMRA | about 1 year ago | $20 1112.04% upside | $10.25 | TheFly | Previous targets (0) |
 Intra-Cellular Therapies, Inc. ITCI | about 1 year ago | $100 -24.16% downside | $76.06 | StreetInsider | Previous targets (0) |
 Insmed Incorporated INSM | about 1 year ago | $82 -35.64% downside | $57.17 | StreetInsider | |
 Adaptimmune Therapeutics plc ADAP | over 1 year ago | $3 4809.98% upside | $1.2 | TheFly | Previous targets (0) |
 Immatics N.V. IMTX | over 1 year ago | $16 180.70% upside | $11.08 | TheFly | Previous targets (0) |
 Amylyx Pharmaceuticals, Inc. AMLX | over 1 year ago | $3 -61.73% downside | $1.82 | StreetInsider | |
 EyePoint Pharmaceuticals, Inc. EYPT | over 1 year ago | $30 171.73% upside | $11.2 | StreetInsider | Previous targets (0) |
 Immuneering Corporation IMRX | over 1 year ago | $8 136.68% upside | $2.75 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Ashwani Verma
Bank of America Securities
100%
win rate
Covering:
Bill Maughan
Canaccord Genuity
20%
win rate